We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are going to take a look at where ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options begin trading today, for the April 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay ...

Below is Validea's guru fundamental report for GILEAD SCIENCES INC (GILD). Of the 22 guru strategies we follow, GILD rates highest using our Earnings Yield Investor model based on the published ...

Fintel reports that on January 10, 2025, Morgan Stanley upgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Equal-Weight to Overweight. As of December 23, 2024, the average one-year ...

Fintel reports that on January 10, 2025, Morgan Stanley upgraded their outlook for Gilead Sciences (SNSE:GILD) from Equal-Weight to Overweight. There are 2,888 funds or institutions reporting ...

Gilead Sciences (GILD ... Elsewhere, the Dow saw an upswing of 0.25%, while the tech-heavy Nasdaq depreciated by 0.06%. Prior to today's trading, shares of the HIV and hepatitis C drugmaker ...

Gilead will lead further development efforts ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

Among the largest underlying components of XBI, in trading today Neurocrine Biosciences, Inc. (Symbol: NBIX) is up about 1.2%, Gilead Sciences Inc (Symbol: GILD) is trading flat, and BioMarin ...

Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...